Recursion Pharmaceuticals (RXRX) stock price is down over 3% today. Co-founder and CEO, Chris Gibson, weighs in on clinical-stage biotechnology. RXRX uses a recursion operating system, a multi-layer system for generating, analyzing, and deriving insights from biological and chemical datasets. Recursion Pharmaceuticals partners with Roche and Genentech.
22 Dec 2021
Morning Trade Live
14 Nov 2022
Market On Close
28 Sep 2022
Trading 360
28 Sep 2022
The Watch List
09 Dec 2022
Market On Close
14 Dec 2022